Mcl-1 inhibition enhances the proapoptotic effects of vemurafenib in melanoma cells

被引：0
|
作者：
Sarif, Z. [1 ,2 ]
Dogan, A. [1 ]
Richtig, G. [3 ]
Fechner, H. [4 ]
Kreppel, F. [2 ]
Eberle, J. [1 ]
机构：
[1] Charite Univ Med Berlin, Berlin, Germany
[2] Univ Witten Herdecke, Witten, Germany
[3] Med Univ Graz, Graz, Austria
[4] Tech Univ Berlin, Fachgebiet Angew Biochem, Berlin, Germany
来源：
EXPERIMENTAL DERMATOLOGY | 2021年 / 30卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
P216
引用
收藏
页码：E106 / E106
页数：1
相关论文
共 50 条
  • [1] Mcl-1 Inhibitor enhances the proapoptotic effects of vemurafenib in melanoma cell lines
    Sarif, Z.
    Dogan, A.
    Eberle, J.
    EXPERIMENTAL DERMATOLOGY, 2023, 32 (04) : E108 - E108
  • [2] Mcl-1 targeting strategies unlock the proapoptotic potential of TRAIL in melanoma cells
    Sarif, Zina
    Tolksdorf, Beatrice
    Fechner, Henry
    Eberle, Juergen
    MOLECULAR CARCINOGENESIS, 2020, 59 (11) : 1256 - 1268
  • [3] Inhibition of Mcl-1 enhances Pevonedistat-triggered apoptosis in osteosarcoma cells
    Zhang, Yi
    Shi, Chengcheng
    Yin, Li
    Zhou, Wei
    Wang, Haitao
    Seng, Jingjing
    Li, Wencai
    EXPERIMENTAL CELL RESEARCH, 2017, 358 (02) : 234 - 241
  • [4] BRAF/MEK inhibitors selectively prime melanoma for Mcl-1 dependence and sensitize to Mcl-1 inhibition
    Kump, Karson J.
    Miao, Lei
    Ansari, Nurul
    Lombard, David B.
    Nikolovska-Coleska, Zaneta
    CANCER RESEARCH, 2019, 79 (13)
  • [5] The role of MITF and Mcl-1 proteins in the antiproliferative and proapoptotic effect of ciprofloxacin in amelanotic melanoma cells: In silico and in vitro study
    Beberok, Artur
    Rok, Jakub
    Rzepka, Zuzanna
    Marciniec, Krzysztof
    Boryczka, Stanislaw
    Wrzesniok, Dorota
    TOXICOLOGY IN VITRO, 2020, 66
  • [6] Countering TRAIL resistance in melanoma cells by Mcl-1 silencing
    Sarif, Z.
    Tolksdorf, B.
    Fechner, H.
    Eberle, J.
    EXPERIMENTAL DERMATOLOGY, 2023, 32 (04) : E106 - E106
  • [7] Overcoming TRAIL Resistance in Melanoma Cells by Mcl-1 Silencing
    Sarif, Z.
    Tolksdorf, B.
    Fechner, H.
    Eberle, J.
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2019, 17 : 30 - 30
  • [8] BIM phosphorylation enhances its proapoptotic activity through down-regulation of the interaction with MCL-1
    Lu, Jianghua
    Quearry, Bonnie
    Harada, Hisashi
    CANCER RESEARCH, 2006, 66 (08)
  • [9] Proteasomal Degradation of Mcl-1 by Maritoclax Induces Apoptosis and Enhances the Efficacy of ABT-737 in Melanoma Cells
    Pandey, Manoj K.
    Gowda, Krishne
    Doi, Kenichiro
    Sharma, Arun K.
    Wang, Hong-Gang
    Amin, Shantu
    PLOS ONE, 2013, 8 (11):
  • [10] Allosteric inhibition of antiapoptotic MCL-1
    Susan Lee
    Thomas E Wales
    Silvia Escudero
    Daniel T Cohen
    James Luccarelli
    Catherine G Gallagher
    Nicole A Cohen
    Annissa J Huhn
    Gregory H Bird
    John R Engen
    Loren D Walensky
    Nature Structural & Molecular Biology, 2016, 23 : 600 - 607
12345